Endo International PLC (ENDP)

15.80
NASDAQ : Health Care
Prev Close 15.82
Day Low/High 15.67 / 16.14
52 Wk Low/High 12.56 / 63.71
Avg Volume 5.69M
Exchange NASDAQ
Shares Outstanding 222.88M
Market Cap 3.53B
EPS -7.60
P/E Ratio 1.74
Div & Yield N.A. (N.A)

Latest News

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Endo International Plc

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Endo International Plc

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Endo International plc securities (NASDAQ:ENDP) from September 28, 2015 through November 2, 2016,...

Generics Fuel Solid 3Q for Taro Pharmaceutical

Generics Fuel Solid 3Q for Taro Pharmaceutical

Days after price fixing allegations go public over generic drugs, Taro posts financials showing net sales up thanks to, yes that's right, its U.S. generic drug business.

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Endo International Plc And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Endo International Plc And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc ("Endo" or the "Company") (Nasdaq: ENDP).

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Endo International Plc And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Endo International Plc And Encourages Investors With Losses To Contact The Firm

Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Endo International plc ("Endo" or the "Company") (Nasdaq: ENDP) concerning possible violations of federal securities laws between...

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Which stocks have shown these patterns in the past week.

After Big Drop in Generics, Ride the Rebound

After Big Drop in Generics, Ride the Rebound

Investors have a buying opportunity because the damage by any criminal charges is far less than what is likely to be inflicted by the feds.

Looking Under the Hood at Why These 3 Stocks Flopped on Thursday

Looking Under the Hood at Why These 3 Stocks Flopped on Thursday

Here is the real story behind three equities that just took major hits. Are any of them value plays?

Biopharma: It's Darkest Before the Dawn

Biopharma: It's Darkest Before the Dawn

Thursday felt a lot like capitulation in this space. I was buying.

5 Things You Must Know Before the Market Opens Friday

5 Things You Must Know Before the Market Opens Friday

U.S. stock futures point lower on Friday ahead of the monthly U.S. jobs report; Starbucks' profit jumps but same-store sales are flat; GoPro tanks.

SHAREHOLDER ALERT: Investigation Of Endo International PLC Announced By Holzer & Holzer, LLC

SHAREHOLDER ALERT: Investigation Of Endo International PLC Announced By Holzer & Holzer, LLC

Holzer & Holzer, LLC is investigating whether certain statements made by Endo International PLC ("Endo International" or the "Company") (NASDAQ:ENDP) regarding its business and operations complied with federal...

Generics Hit by Report on Pending DOJ Price Fixing Charges

Generics Hit by Report on Pending DOJ Price Fixing Charges

The DOJ's investigation has been under way for at least two years and a number of companies have reported receiving subpoenas related to the investigation.

Shares of Endo (ENDP), Generic Drug Makers Plunge on Potential DoJ Charges

Shares of Endo (ENDP), Generic Drug Makers Plunge on Potential DoJ Charges

Endo (ENDP) and other generic drug makers could reportedly face charges by the Department of Justice by year-end.

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.

Endo (ENDP) Stock Slumps, Oppenheimer: 'Not Surprised' by CEO Change

Endo (ENDP) Stock Slumps, Oppenheimer: 'Not Surprised' by CEO Change

Oppenheimer analysts say Endo's (ENDP) recent management shake-up indicates the company is re-focusing on its generics business, rather than M&As.

Trending Tickers: TWTR, VRX, ENDP, RIG

Trending Tickers: TWTR, VRX, ENDP, RIG

It appears Twitter will need more than takeover chatter to stay aloft, Oppenheimer analysts say.

Changes at the Top for Endo Could Benefit Its Smaller Partners

Changes at the Top for Endo Could Benefit Its Smaller Partners

The promotion of Paul Campanelli to CEO indicates a change in the company's focus from acquiring other firms to its roots as a generic pharmaceutical firm.

7 Big-Volume Stocks to Trade for Big Gains

7 Big-Volume Stocks to Trade for Big Gains

Here's a technical look at how to trade some of the most active stocks on the market.